STOCK TITAN

Assurant (AIZ) EVP Lonergan sells 7,000 shares under Rule 10b5-1 plan

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Assurant, Inc. executive Robert Lonergan, EVP and Chief Strategy & Transformation Officer, sold 7,000 shares of common stock in an open-market transaction at a weighted average price of about $262.71 per share. The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 20, 2026. After the sale, Lonergan directly holds 27,373.727 shares of Assurant stock, a figure that includes restricted stock units.

Positive

  • None.

Negative

  • None.

Insights

Pre-planned executive share sale with modest scale and remaining stake.

Executive vice president Robert Lonergan sold 7,000 Assurant shares at a weighted average of $262.7097 per share. The transaction is coded as an open-market sale and is not tied to any derivative exercise in this filing.

All sales occurred under a pre-established Rule 10b5-1 trading plan adopted on March 20, 2026, indicating they were scheduled in advance rather than timed discretionarily. Following the sale, Lonergan still directly owns 27,373.727 shares, including restricted stock units, suggesting continued equity exposure.

Insider Lonergan Robert
Role EVP, CSTO
Sold 7,000 shs ($1.84M)
Type Security Shares Price Value
Sale Common Stock 7,000 $262.7097 $1.84M
Holdings After Transaction: Common Stock — 27,373.727 shares (Direct, null)
Footnotes (1)
  1. All of the sales set forth on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 20, 2026. The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.2400 through $264.6100, inclusive. The Reporting Person undertakes to provide Assurant, Inc., any security holder of Assurant, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to Form 4. Includes restricted stock units.
Shares sold 7,000 shares Open-market sale of Assurant common stock
Weighted average sale price $262.7097 per share Price for sold shares
Post-transaction holdings 27,373.727 shares Direct ownership after sale, includes RSUs
Sale price range $261.2400–$264.6100 per share Range of trade prices in the sale
Trading plan adoption date March 20, 2026 Rule 10b5-1 plan used for these sales
Rule 10b5-1 trading plan regulatory
"All of the sales set forth on this Form 4 were made pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
restricted stock units financial
"Includes restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lonergan Robert

(Last)(First)(Middle)
C/O ASSURANT, INC.
260 INTERSTATE NORTH CIRCLE SE

(Street)
ATLANTA GEORGIA 30339

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ASSURANT, INC. [ AIZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, CSTO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/22/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/22/2026S7,000(1)D$262.7097(2)27,373.727(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. All of the sales set forth on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 20, 2026.
2. The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.2400 through $264.6100, inclusive. The Reporting Person undertakes to provide Assurant, Inc., any security holder of Assurant, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to Form 4.
3. Includes restricted stock units.
/s/ Anne Holman, Attorney-in-Fact06/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

How many Assurant (AIZ) shares did Robert Lonergan sell in this Form 4?

Robert Lonergan sold 7,000 shares of Assurant common stock in this transaction. The sale was executed as an open-market trade at a weighted average price of about $262.71 per share, according to the Form 4 disclosure and its accompanying footnotes.

What price did Robert Lonergan receive per Assurant (AIZ) share in the sale?

The reported sale price is a weighted average of $262.7097 per share. Footnotes explain the shares were sold in multiple trades at prices between $261.2400 and $264.6100, and detailed trade-level pricing is available on request from the company or the SEC.

Did Robert Lonergan use a Rule 10b5-1 trading plan for this Assurant (AIZ) sale?

Yes. The Form 4 footnotes state that all sales were made under a Rule 10b5-1 trading plan adopted on March 20, 2026. Such plans pre-schedule trades, indicating these transactions were arranged in advance rather than timed based on short-term market developments.

How many Assurant (AIZ) shares does Robert Lonergan own after this transaction?

After the sale, Robert Lonergan directly owns 27,373.727 Assurant shares. A footnote clarifies that this total includes restricted stock units, reflecting both vested and certain unvested equity-based compensation awards in his remaining position.

Were derivatives or options involved in Robert Lonergan’s Assurant (AIZ) Form 4?

No derivative transactions are reported in this Form 4. The filing lists only a non-derivative common stock sale of 7,000 shares. The derivative section is empty, indicating no option exercises, conversions, or other derivative events in this particular disclosure.